AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2012

Apr 23, 2012

33510_dirs_2012-04-23_be4fa6f5-e764-4510-b76b-8cd109299b1d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2012-02-07

Reporting Person: Babcock Dwight William (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-17	Common Stock	P	10000	$0.54	Acquired	195873	Direct
2012-02-21	Common Stock	P	500	$0.51	Acquired	196373	Direct

Footnotes

F1: This amendment is being filed to correct the total securities beneficially owned in Column 5. No changes have been made to the reported purchases.